Insights Into Classical Hodgkin Lymphoma (CHL)
Perspectives on treatment patterns of community physicians from across the US on the management of first-line and relapsed/refractory CHL
October 12, 2020
Faculty Chair
Radhakrishnan Ramchandren, MD
The University of Tennessee Medical Center, TN, US
DISCUSSION TOPICS OF THE MEETING
- First-Line Treatment of CHL
- Treatment of Relapsed/Refractory CHL
- Key Takeaways and Meeting Evaluation
GEOGRAPHIC REPRESENTATION
- The group of advisors will consist of community oncologists representative for the US.
